Global Central Nervous System Biomarkers Market
Biomarkers are used to evaluate and determine pathogenic processes, therapeutic interventions, as well as to predict treatment response. The applications of biomarkers are numerous. They are often used in the regulatory decision-making process and drug development process as they have the potential to improve the effectiveness of drug development process. Moreover, they provide vital information about the patient at almost every stage of care.
Increase in focus on the development of safe and effective biosimilars for various diseases is expected to augment growth of the global central nervous system biomarkers market over the forecast period. For instance, in March 2017, Hospices Civils de Lyon began clinical trial to evaluate CSF biomarkers of Alzheimer’s disease in geriatric patients with new-onset epilepsy.
Moreover, increase in research and development is expected to boost the growth of the global central nervous system biomarkers market. For instance, in 2016, The Tufts Center for the Study of Drug Development released its newest estimate for the cost to develop and bring a drug to market, which is US$ 2.6 billion, and announced that the costs of drug development are increasing with a rapid pace.
To Get Free Covid-19 Impact PDF Brouchure of this Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2434
- Drug Discovery & Development
- Personalized Medicines
- Disease Risk Assessment
By Disease Indication:
- Alzheimer’s Disease
- Multiple Sclerosis
- Parkinson’s Disease
- Traumatic Brain Injury
- Other Neurological Conditions
By End User:
- Diagnostic Labs
- Research Centers
- North America
- Asia Pacific
- Latin America
- Middle East
To Get more information Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2434
Unfavorable reimbursement situation for discovery and development of biomarkers and high cost of validation process is expected to hamper the growth of the global central nervous system biomarkers market.
Among regions, North America is expected to witness substantial growth of the global central nervous system biomarkers market due to expansion activities by market players in the region. For Instance, in January 2017, bioMérieux and Banyan Biomarkers entered into a partnership to commercialize Banyan’s proprietary tests for use in in vitro diagnostics, with preferred rights for its VIDAS immunoassays range. Moreover, the two companies will continue to explore co-development opportunities in the area of TBI and critical care.
Moreover, Asia Pacific is expected to witness significant growth of the global central nervous system biomarkers market due to the high prevalence of Alzheimer’s disease in the region. For instance, as per the Alzheimer’s Disease International (ADI), in 2015, over 23 million people suffered from dementia in Asia Pacific.
Major players active in the global central nervous system biomarkers market are Merc & Co. Inc., Applied Neurosolutions Inc., Exonhit Therapeutics, Avacta Group plc., Diagenic ASA, Banyan Biomarkers, Aposense, Alseres Pharmaceuticals Inc., Adlyfe Inc., Abastar MDX Inc., Abiant Inc., Enzo Biochem Inc., Thermo fisher scientific, Acumen Pharmaceuticals Inc., EKF Diagnostics Holdings Inc., and Avid Radiopharmaceuticals Inc.
Purchase This Premium Report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/2434
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Central Nervous System Biomarkers Market Size Analysis from 2021 to 2028
1.6 COVID-19 Outbreak: Central Nervous System Biomarkers Market Industry Impact
Chapter 2 Central Nervous System Biomarkers Market Competition by Types, Applications, and Top Regions and Countries
2.1 Central Nervous System Biomarkers Market (Volume and Value) by Type
2.3 Central Nervous System Biomarkers Market (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Central Nervous System Biomarkers Market Sales, Consumption, Export, Import by Regions
Chapter 5 North America Central Nervous System Biomarkers Market Analysis
Chapter 6 East Asia Central Nervous System Biomarkers Market Analysis
Chapter 7 Europe Central Nervous System Biomarkers Market Analysis
Chapter 8 South Asia Central Nervous System Biomarkers Market Analysis
Chapter 9 Southeast Asia Central Nervous System Biomarkers Market Analysis
Chapter 10 Middle East Central Nervous System Biomarkers Market Analysis
Chapter 11 Africa Central Nervous System Biomarkers Market Analysis
Chapter 12 Oceania Central Nervous System Biomarkers Market Analysis
Chapter 13 South America Central Nervous System Biomarkers Market Analysis
Chapter 14 Company Profiles and Key Figures in Central Nervous System Biomarkers Market Business
Chapter 15 Central Nervous System Biomarkers Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027